Die Kreiskliniken Reutlingen GmbH ist der Träger des Klinikum am Steinenberg in Reutlingen, der Ermstalklinik in Bad Urach, der Albklinik in Münsingen und des MVZ Gammertingen. Der Landkreis Reutlingen ist Gesellschafter der Kreiskliniken Reutlingen GmbH.

During the past decade, Klinikum Am Steinenberg conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Am Steinenberg" #1 sponsor was "German Breast Group" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "AGO Study Group" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Am Steinenberg" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Albertinen-Krankenhaus Hamburg" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Am Steinenberg" are "Breast Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Ovarian Cancer" (2 trials), "COVID-19, Hydroxychloroquine Sulfate" (1 trials) and "Coronary Arteriosclerosis" (1 trials). Many other conditions were trialed in "Klinikum Am Steinenberg" in a lesser frequency.

Most popular intervention types in "Klinikum Am Steinenberg" are "Drug" (12 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "Placebo" (2 trials), "5-FU/LV" (1 trials) and "Agent Paclitaxel-coated balloon" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Am Steinenberg" are 10 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Am Steinenberg". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Klinikum Am Steinenberg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Am Steinenberg, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".